MTIM
ATOS icon

Marathon Trading Investment Management’s Atossa Therapeutics ATOS Stock Holding History

Marathon Trading Investment Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,333
Closed -$176K – 320
2021
Q4 		$176K Sell
7,333
-32,067
-81% -$1.17M 0.01% 234
2021
Q3 		$1.93M Sell
39,400
-29,447
-43% -$1.71M 0.14% 93
2021
Q2 		$6.53M Buy
68,847
+52,060
+310% +$2.76M 0.65% 38
2021
Q1 		$531K Buy
+16,787
New +$613K 0.05% 203

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marathon Trading Investment Management's ATOS Position: Q1 2023 in Review

Marathon Trading Investment Management sold out of Atossa Therapeutics (ATOS) in Q1 2023, closing a stake of 667 shares — an estimated $5.29K sold.

Marathon Trading Investment Management first reported a position in ATOS in Q1 2022 and held it in 4 quarters. The position peaked at $13K in Q1 2022. 45 funds tracked by Wall St. Rank hold ATOS as of Q1 2023.

  • Marathon Trading Investment Management reported no remaining Atossa Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Marathon Trading Investment Management sold 667 Atossa Therapeutics shares in Q1 2023, an estimated $5.29K.
  • Marathon Trading Investment Management first reported a position in Atossa Therapeutics in Q1 2022 and held it in 4 quarters.
  • Marathon Trading Investment Management's Atossa Therapeutics position peaked at $13K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2023.

Based on Marathon Trading Investment Management's 13F filing for Q1 2023, filed 12 May 2023.